2010
DOI: 10.1097/mot.0b013e328334f074
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair

Abstract: ASCs may ultimately represent a valuable therapeutic option in tissue rescue and repair based on their ready availability, proangiogenesis and antiapoptotic factor secretion, immunomodulatory effects, and capacity for multilineage differentiation and ready expansion.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
106
0
4

Year Published

2011
2011
2016
2016

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 141 publications
(116 citation statements)
references
References 81 publications
3
106
0
4
Order By: Relevance
“…Human ASCs were transplanted into damaged disc segments in rats, and were found to restore the degenerated intervertebral disc [75]. Based on the promising results of animal model studies, certain clinical trials have also been initiated [78]. There is a growing number of preclinical studies examining the potential of ASCs.…”
Section: Neuronal Differentiationmentioning
confidence: 99%
“…Human ASCs were transplanted into damaged disc segments in rats, and were found to restore the degenerated intervertebral disc [75]. Based on the promising results of animal model studies, certain clinical trials have also been initiated [78]. There is a growing number of preclinical studies examining the potential of ASCs.…”
Section: Neuronal Differentiationmentioning
confidence: 99%
“…Such cells have already been used to correct cranial defects in humans, 119 and preliminary studies in man to rectify cardiovascular 134,135 and soft tissue [136][137][138] defects hold hope for the future use of ADSCs in the treatment of muscle and cartilage defects and heart infarcts. However, before this becomes a reality, there are a number of technical problems that need to be overcome.…”
Section: Fat and The Futurementioning
confidence: 99%
“…Briefly, lipoaspirate (300-600 ml) was been isolated and characterized (4,49), and are currently being tested in clinical trials (12). MSCs are frequently washed repeatedly to remove erythrocytes and leukocytes with Hanks' balanced salt solution (HBSS; Gibco, obtained from the stromal-vascular fraction (SVF) of AT cells.…”
Section: Introductionmentioning
confidence: 99%